Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMG 531 (Romiplostim) in Splenectomized ITP Patients
NCT00102323Phase 3Completed
- Sponsor
- Amgen
- Start
- Mar 2005
- Primary completion
- Sep 2006
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of romiplostim in immune thrombocytopenic purpura (ITP), sponsored by Amgen. Started Mar 2005; status: completed.
02
Drugs
romiplostim
03
Conditions
immune thrombocytopenic purpura (ITP)
Beyond the preview
Go deeper on NCT00102323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00102323.